Harlequin blends Colombian Gold, Thai, and Swiss Landrace to form a sativa-dominant hybrid, with about 75 percent Sativa and 25 percent Indica. Its cannabinoid balance skews toward a near equal CBD to THC ratio, typically with THC in the 7 to 15 percent range and CBD around 4 to 10 percent. The aroma is mango-infused with earthy musk, while the palate carries herbal and wood notes accented by spice and a touch of sweetness.
The effect is a relaxing, calming body experience that still leaves the mind clear and capable of focus and creative uplift. Users often report a combination of body high, focus, and uplifting mood, with the strain offering potential relief for arthritis, chronic pain, depression, fatigue, fibromyalgia, headaches, inflammation, migraines, PTSD, and stress. The relatively moderate THC level makes mindful use easier for many patients, though some may experience dry mouth and eyes, with mild nausea or headaches in harsher doses.
Cultivation-wise, Harlequin yields well indoors and typically finishes flowering in sixty to seventy days. Visually, it presents dense, thick nugs heavily coated with trichomes. In medical contexts, its resinous profile supports pain relief across body and head discomforts, while its sativa-forward balance helps maintain alertness and daytime functionality alongside calming relief.